SuperGen
ClosedDedicated to the development of novel cancer therapies.
Public · Dublin, United States · Founded 1991 · $391.6M raised
- Headquarters
- Dublin, California
- Employees
- 201–500
- Founded
- 1991
- Business Model
- B2B
- Website
- supergen.com
- Total Funding
- $391.6M
- Last Round
- $375.0M Corporate RoundOct 2009
- Rounds
- 2
- Type
- Public
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
SuperGen, Inc. was a Dublin, California-based pharmaceutical company dedicated to the discovery, acquisition, rapid development, and commercialization of cancer therapeutics. Founded in 1991 and listed on Nasdaq (SUPG), the company built a portfolio of oncology drugs including Dacogen (decitabine). In 2011, SuperGen merged with Astex Therapeutics to form Astex Pharmaceuticals, Inc., which was subsequently acquired by Otsuka Pharmaceutical.
Summary
SuperGen is a Biotech company based in Dublin, United States, founded in 1991. It has raised $391.6M in total across 2 rounds, most recently a $375.0M Corporate Round in Oct 2009. Investors include GlaxoSmithKline.
Funding History
Oct 2009
Sign up to see all 2 events
Funding: Venture Round through Corporate Round. Amounts, valuations, and investors where available.
Investors
Similar Companies
China's leading blood products manufacturer
One of the world's largest contract research organizations (CROs), providing end-to-end clinical ...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/supergen"><img src="https://indexed.vc/api/badge/company/supergen" alt="SuperGen on Indexed.vc" width="260" height="76" /></a>